|
BioSystems International
4012 Debrecen
|
Dr. Kurucz István
Tel: +36 52 321 562
|
Biosystems International (BSI) a biotech- nology company focused on the development of novel monoclonal antibody-based diagnostics for cancer and metabolic diseases has established a licensing agreement with the Lohocla Research Corporation for the use of BSI’s patented monoclonal antibody proteo- mics platform for the discovery of novel alcoholism liver disease biomarkers in blood.
Biosystems International and Microbiochips sign collaboration agreement to commer- cialize PlasmaScan™ antibody microarray products.